… for inoperable breast liver metastases. In summary, data from the studies included has
demonstrated that radioembolization of breast cancer liver metastases with yttrium-90 confers a …

… transarterial hepatic radioembolization (TARE) treatment with yttrium-90 … breast cancer
with liver-dominant metastatic disease. … breast cancer with unresectable, chemotherapy-refractory …

… In conclusion, for patients with chemo-refractory breast cancer with metastases to the liver,
achieving a mean tumour dose >70 Gy in the five largest tumours in each treated liver lobe …

… abnormalities in liver function tests. Overall, our results suggest that radioembolization
might be a safe and effective treatment option for patients with unresectable liver sarcomas. …

… body radiation therapy, intensity modulated radiation therapy, or radioembolization) and
systemic drugs, are used for patients with unresectable primary liver tumors [4,5]. Most LRTs are …

… study is to evaluate the efficacy of Yttrium-90 (Y90) radioembolization in patients with breast
… after TARE of hepatic metastases from breast cancer found that treatment within 6 months of …

… survival reports after surgical resection of hepatic metastases. TARE may prove to provide
a competitive nonsurgical alternative to resection in younger patients with advanced disease. …

… (EANM), radioembolization is indicated for unresectable liver tumors, both primary tumors and
… could provide clinical survival benefits for breast cancer patients with liver metastasis after …

… and immunotherapy for the treatment of hepatocellular carcinoma (HCC) has been
reported. … of combination of radioembolization with yttrium-90 microspheres (Y90-radioembolization) …

… proven metastatic breast cancer to the liver, active unresectable … mg/dL, and no other evidence
of liver disease. Patients with a life … Y-90 radioembolization of hepatic metastases. Median …